10x Genomics, a life sciences leader focused on mastering biology to advance human health, has opened its Singapore manufacturing facility and commercial hub.
The addition of the company’s first manufacturing facility outside the U.S. is part of 10x Genomics’ ongoing investments to integrate and scale its operations network to build a more robust supply chain and better serve customers globally. The manufacturing center provides additional capacity for 10x Genomics’ portfolio of consumables for single-cell and spatial analysis. The site also serves as the APAC commercial hub, strengthening the company’s in-region sales, marketing and customer support capabilities.
10x Genomics’ Singapore hub occupies more than 53,000 square feet of the Solaris@Kallang 164 complex, including state-of-the art, automated production suites for reagent manufacturing and a fully equipped, Biosafety Level-2 lab for training customers and partners on all 10x Genomics’ single cell and spatial technologies. The site, which began initial operations in late 2020, also includes a distribution center, supporting warehouse space and open office areas that encourage collaboration and teamwork. 10x Genomics currently employs more than 80 employees in Singapore in manufacturing, corporate functions and commercial roles.
As 10x Genomics continues to expand its global reach, the Asia-Pacific region is an important market for the company, representing 25% of global sales in the first half of 2021. The company selected Singapore as the ideal location for its expansion because of the Singapore government’s demonstrated commitment to the biotechnology industry and business-friendly practices, world-class manufacturing expertise and strong talent pool.
(Source: 10x Genomics, Inc.)